Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №6 (2024) > Clinical case of autoimmune atrophic gastritis

Clinical case of autoimmune atrophic gastritis

Natalya N. Dekhnich , Pavel Р. Kirsov , Inna A. Sysoeva , Anastasiia S. Gaidaichuk

For citation:


  • Abstract
  • About the Author
  • References

Abstract

The article presents a clinical case of a 62-year-old female patient with a diagnosis of autoimmune atrophic gastritis, who has been troubled by symptoms of dyspepsia for 5 years. In October 2019, she was diagnosed non-atrophic gastritis associated with Helicobacter pylori, anti-Helicobacter pylori therapy was performed, but the symptoms of the disease continued to bother. This article presents key studies that identify 
autoimmune atrophic gastritis. The characteristic endoscopic signs of this disease and the current treatment tactics are described. Autoimmune gastritis is a chronic autoimmune disease with an insufficiently studied etiology. Many questions concerning of this nosology remain open to new researches.
Keywords: autoimmune gastritis, pernicious anemia, iron deficiency anemia, neuroendocrine tumors, adenocarcinoma, endoscopy.

About the Author

Natalya N. Dekhnich 1 , Pavel Р. Kirsov 2 , Inna A. Sysoeva 1 , Anastasiia S. Gaidaichuk 1

1 Smolensk State Medical University, Smolensk, Russia

2 Smolensk Regional Clinical Hospital, Smolensk, Russia

References

1. Плотникова Е.Ю. Аутоиммунный гастрит. Медицинский совет. 2023;17(23):157-167.
Plotnikova E.Y. Autoimmune gastritis. Medical advice 2023;17(23): 157-167 (in Russian).
2. Костюкевич О.И. Атрофический гастрит: что мы понимаем под этим состоянием. Современные подходы к диагностике и лечению. Главный врач Юга России. 2011;2(25):6-10.
Kostyukevich O.I. Atrophic gastritis: what do we mean by this condition? Modern approaches to diagnosis and treatment. The chief physician of the South of Russia 2011;2(25):6-10 (in Russian).
3. Koivurova OP, Koskela R, Blomster T et al. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test Anticancer Res 2021;41(11):5527-37.
4. Nehme F, Rowe K, Palko W et al. Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach. Clin J Gastroenterol 2020;13(3):299-307.
5. Radić M. Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases. World J Gastroenterol 2014;20(36):12839-46.
6. Лосик Е.А., Селиванова Л.С., Антонова Т.В. и др. Морфологические критерии диагноза аутоиммунного гастрита. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(5):13-20.
Losik E.A., Selivanova L.S., Antonova T.V. and others. Morphological criteria for the diagnosis of autoimmune gastritis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2016;26(5):13-20 (in Russian).
7. Смирнов И.В. Клинический случай эндоскопической диагностики аутоиммунного атрофического гастрита. Клинический разбор в общей медицине. 2022;6:30-35.
Smirnov I.V. Clinical case of endoscopic diagnosis of autoimmune atrophic gastritis. Clinical review for general practice. 2022;6:30-5 (in Russian).
8. Orgler E, Dabsch S, Malfertheiner P, Schulz С Autoimmune Gastritis: Update and New Perspectives in Therapeutic Management. Curr Treat Options Gastroenterol 2023 Mar; 21:64-77.
9. Ивашкин В.Т., Маев И.В., Лапина Т.Л. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации «Эндоскопическое общество РЭНДО» по диагностике и лечению гастрита, дуоденита. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(4):70-99.
Ivashkin V.T., Mayev I.V., Lapina T.L. et al. Clinical recommendations of the Russian Gastroenterological Association and the association «Endoscopic Society of RANDO» on the diagnosis and treatment of gastritis, duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021;31(4):70-99 (in Russian).
10. Dixon MF, Genta RM, Yardley JH, Correa P Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20(10):1161-81.
11. Dixon MF, Genta RM, Yardley JH, Correa P Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997;2(s1):17-24.
12. Гагаев Р.А., Пирогов С.С., Митраков А.А. и др. Возможности близкофокусной узкоспектральной эндоскопии NBI Dual Focus в дифференциальной диагностике полной и неполной кишечной метаплазии слизистой оболочки желудка. Экспериментальная и клиническая гастроэнтерология. 2022;201(5):12-22.
Gagaev R.A., Pirogov S.S., Mitrakov A.A. et al. The possibilities of close-focus narrow-spectral NBI Dual Focus endoscopy in the differential diagnosis of complete and incomplete intestinal metaplasia of the gastric mucosa. Experimental and clinical gastroenterology 2022;201(5):12-22 (in Russian).
13. Park JY, Lam-Himlin D, Vemulapalli R Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 2013;77(2):284-92.
14. Toh BH, Sentry JW, Alderuccio F The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol Today 2000;21(7):348-54.
15. Белова Г.В., Мельченко Д.С., Коваленко Т.В., Карпова Е.С. Каскад Correa: эндоскопические и иммуногистохимические параллели. Экспериментальная и клиническая гастроэнтерология. 2012;10:17–21.
Belova G.V., Melchenko D.S., Kovalenko T.V., Karpova E.S. Cascade Correa: endoscopic and immunohistochemical parallels. Experimental and clinical gastroenterology 2012;10:17–21 (in Russian).
16. Correa P, Fontham ET, Bravo JC et al Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92(23):1881-8.
17. Kaltsas G, Grozinsky-Glasberg S, Alexandraki KI et al. Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clin Endocrinol (Oxf) 2014;81(2):157-68.
18. Vannella L., Lahner E., Osborn J. et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010;31(9):1042-50.
19. Vannella L, Sbrozzi-Vanni A, Lahner E et al. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment Pharmacol Ther 2011;33(12):1361-9.
20. Dickey W, Kenny BD, McMillan SA et al. Gastric as well as duodenal biopsies may be useful in the investigation of iron deficiency anaemia. Scand J Gastroenterol 1997;32(5):469-72.
21. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1(3):87-97.
22. Miwata T, Quach DT, Hiyama T et al. Interobserver and intraobserver agreement for gastric mucosa atrophy. BMC Gastroenterol 2015;15:95.
23. Kotelevets SM, Chekh SA, Chukov SZ. Updated Kimura-Takemoto classification of atrophic gastritis. World J Clin Cases 2021;9(13):3014-23.
24. Maric L, Castaneda D, Singh H et al. Kimura-Takemoto Classification: A Tool to Predict Gastric Intestinal Metaplasia Progression to Advanced Gastric Neoplasia. Dig Dis Sci 2022; 67(8):4092-9.
25. Song JH, Kim SG, Jin EH et al. Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy. Gut and Liver 2017;11(5):612-9.
26. Pimentel-Nunes P, Libânio D, Lage J et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 2016;48(8):723-30.
27. Capelle LG, de Vries AC, Haringsma J et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71(7):1150-8.
28. Ben Slama S, Ben Ghachem D, Dhaoui A et al. Autoimmune gastritis: assessment of OLGA and OLGIM staging systems. Tunis Med 2017;95(4):262-7.
29. Oberg K Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2011;18(s1):17-25.
30. O’Toole D, Grossman A, Gross D et al. Mallorca Consensus Conference participants. European Neuroendocrine Tumor Society. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. Neuroendocrinology 2009;90(2):194-202.
31. Annibale B, Azzoni C, Corleto VD et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol 2001;13(12):1449-56.
32. Любимова Н.В., Чурикова Т.К., Томс М.Г., Кушлинский Н.Е. Биохимические маркеры нейроэндокринных опухолей. Вестник Тамбовского ун-та. 2016;21(2):494-510.
Lyubimova N.V., Churikova T.K., Toms M.G., Kushlinsky N.E. Biochemical markers of neuroendocrine tumors. Bulletin of the Tambov University 2016;21(2):494-510.
33. Lahner E, Norman GL, Severi C et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 2009;104(8):2071-9.
34. Rychlíčková J Consequences of Hypoacidity Induced by Proton Pump Inhibitors – a Practical Approach. Klin Onkol 2018;31(6):409-13.

For citation:Dekhnich N.N., Kirsov P.Р., Sysoeva I.A., Gaidaichuk A.S. Clinical case of autoimmune atrophic gastritis. Clinical review for general practice. 2024; 5 (6): 6–11 (In Russ.). DOI: 10.47407/kr2024.5.6.00427


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru